0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

Arch Dermatol. 2012;148(6):677. doi:10.1001/archdermatol.2011.534.
Text Size: A A A
Published online

PRONOUNCED ALLELIC IMBALANCE AT D9S162 IN SKIN SQUAMOUS CELL CARCINOMA OF ORGAN TRANSPLANT RECIPIENTS

In the setting of long-term immunosuppression, such as in organ transplant recipients (OTRs), the incidence of squamous cell carcinoma (SCC) rises dramatically. Chronic UV damage is a major risk factor for this field cancerization, ie, the presence of widespread DNA damage in sun-exposed skin. In this case series of a highly selected SCC sample group, Mühleisen et al demonstrate reduced allelic balance at chromosome 9p21-22 for all SCCs, and OTRs had an even further reduced allelic balance for D9S162, suggesting a common trait for SCC in OTRs.

See Article

MALIGNANCY AND CHRONIC LEG ULCERS AND THE VALUE OF SYSTEMATIC WOUND BIOPSIES

Skin cancers associated with chronic leg ulcers (CLUs) are underrecognized and may result from CLU malignant transformation, usually toward SCC, or may arise de novo. In this prospective cross-sectional study, Senet et al evaluate the association between skin cancers and CLUs that failed to heal despite 3 months of appropriate treatment. Sixteen of 154 nonhealing CLUs were associated with skin cancer. This high frequency of malignant transformation was sufficiently high to consider systematic biopsy of ulcers refractory to 3 or more months of appropriate treatment.

See Article

THE EFFECT OF PATCH TESTING ON SURGICAL PRACTICES AND OUTCOMES IN ORTHOPEDIC PATIENTS WITH METAL IMPLANTS

More than 1 million lower-extremity total joint replacements are completed yearly in the United States, and this number is increasing. Most implants are metal alloys, made from a mixture of 2 or more components. Nickel is a commonly used metal, but nickel hypersensitivity may affect up to 19% of the population. In this medical chart review, Atanaskova Mesinkovska et al demonstrate that although nickel remained the most common relevant allergen, 74% of preimplantation patients showing metal hypersensitivity on patch testing had positive reactions to additional metals, including palladium, cobalt, gold, and chromium. These data support a role for patch testing in patients with a clinical history of metal hypersensitivity before prosthetic device implantation.

See Article

SAFETY OF A NOVEL MICRONEEDLE DEVICE APPLIED TO FACIAL SKIN

Many dermatologic medications are administered topically, but cutaneous absorption is significantly impaired by the stratum corneum. Pretreatment with microneedles may facilitate transepidermal transport of drugs by creating microchannels. In this subject- and live rater–blinded randomized trial, Hoesly et al demonstrate that the microneedle device was safe and well tolerated by patients of both sexes and various skin types and ages. Although no topical medications were used with the device and no data were gathered regarding device efficacy with specific topical products, the device appears to offer a safe and practical mechanism by which to enhance cutaneous absorption of topically applied medications such as anesthetics or cosmeceuticals.

See Article

EFFECT OF A SINGLE-CYCLE ALTERNATIVE DOSING REGIMEN FOR RITUXIMAB FOR RECALCITRANT PEMPHIGUS

Pemphigus is a rare, life-threatening, mucocutaneous, autoimmune blistering disease. Therapeutic options include long-term, high-dose corticosteroid therapy and steroid-sparing agents such as azathioprine, cyclophosphamide, methotrexate, and intravenous immunoglobulin. Rituximab is a chimeric murine-human monoclonal antibody targeting the CD20 antigen on B cells. In published studies of pemphigus, the dosing schedule for rituximab is similar to that indicated for non-Hodgkin B-cell lymphoma, namely 1 cycle of 4 weekly infusions at 375 mg/mm2 of body surface area. In this case series, Matsukura et al demonstrate that an alternative dosing regimen of 100 mg on days 1 and 15 was an effective treatment for pemphigus.

See Article

First Page Preview

View Large
First page PDF preview

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

972 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs